New treatment option for patients who no longer respond to hormone therapy
Results in mouse sepsis model lay foundation for clinical trials
Researchers report that levels of a single molecule predict whether a patient has subtype 1 or subtype 2 of the disease
The work offers a greater understanding of the efficacy of the CF drugs Lumacaftor and Ivacaftor
Case Western Reserve researchers uncover novel drug targets by piecing together receptor structures
Lorcaserin decreased risk for diabetes, induced diabetes remission, and reduced risk of diabetes complications in obese and overweight patients
First study shown to improve the nearly 50 percent rate of relapse in children with high-risk neuroblastoma
Findings suggest long-lasting protection and provide reassurance for women
The super-fast screening technology could help to discover new treatments
Lonza will reveal its next-generation endotoxin automation solution, PyroTec™ Pro Robotic Solution
Insulin tracked through cell using new method combining database, experimental results
Thorough method validation can be tedious, but not doing it right means wasted time, money, and resources
CURRENT ISSUE - October 2025
Move Beyond Policies to Build a Lab Culture Where Safety is Second Nature